Literature DB >> 12543808

Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.

Xiaohui Lin1, William G Nelson.   

Abstract

GSTP1, encoding the pi-class glutathione S-transferase, is commonly inactivated by somatic CpGisland hypermethylation in cancers of the prostate, liver, and breast. We report here thathypermethylation of CpG dinucleotides at the 5' transcriptional regulatory region was sufficient to inhibit GSTP1 transcription in MCF-7 breast cancer cells and that repression of GSTP1 transcription was mediated in part by the methyl-CpG-binding domain (MBD) protein MBD2. MCF-7 breast cancer cells contained only hypermethylated GSTP1 CpG island alleles and failed to express GSTP1 mRNA or GSTP1 polypeptides. In contrast, MCF-7/ADR cells contained only unmethylated GSTP1 CpG island alleles and exhibited abundant GSTP1 expression. Chromatin immunoprecipitation analysis detected the presence of MBD2 and DNMT1 at the GSTP1 promoter in MCF-7 breast cancer cells but not in MCF-7/ADR breast cancer cells. In a test of the contribution of MBD2 to GSTP1 repression in MCF-7 breast cancer cells, transfection of small interference RNA complementary to MBD2 mRNA into MCF-7 cells both reduced MBD2 polypeptide levels and stimulated GSTP1 mRNA expression. These findings implicate MBD2 in GSTP1 silencing associated with somatic GSTP1 CpG island hypermethylation in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543808

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF.

Authors:  Masayuki Sekimata; Yoshimi Homma
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

2.  CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.

Authors:  S M Pulukuri; J S Rao
Journal:  Oncogene       Date:  2006-06-19       Impact factor: 9.867

3.  MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells.

Authors:  Evan P Kransdorf; Shou Zhen Wang; Sheng Zu Zhu; Timothy B Langston; Jeremy W Rupon; Gordon D Ginder
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

4.  MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

Authors:  Xavier Le Guezennec; Michiel Vermeulen; Arie B Brinkman; Wieteke A M Hoeijmakers; Adrian Cohen; Edwin Lasonder; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

5.  Mbd2 contributes to DNA methylation-directed repression of the Xist gene.

Authors:  Helen Barr; Andrea Hermann; Jennifer Berger; Hsin-Hao Tsai; Karen Adie; Anna Prokhortchouk; Brian Hendrich; Adrian Bird
Journal:  Mol Cell Biol       Date:  2007-03-12       Impact factor: 4.272

6.  Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.

Authors:  Mei-Mei Li; Balasubrahmanyam Addepalli; Mei-Juan Tu; Qiu-Xia Chen; Wei-Peng Wang; Patrick A Limbach; Janine M LaSalle; Su Zeng; Min Huang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2015-05-01       Impact factor: 3.922

7.  HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.

Authors:  Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

8.  Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.

Authors:  Dan Zhu; Stephen B Hunter; Paula M Vertino; Erwin G Van Meir
Journal:  Cancer Res       Date:  2011-07-01       Impact factor: 12.701

9.  Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival.

Authors:  Anna M Mileo; Claudia Abbruzzese; Stefano Mattarocci; Emanuele Bellacchio; Paola Pisano; Antonio Federico; Vittoria Maresca; Mauro Picardo; Alessandra Giorgi; Bruno Maras; M Eugenia Schininà; Marco G Paggi
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

10.  Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.

Authors:  Siwang Yu; Tin Oo Khor; Ka-Lung Cheung; Wenge Li; Tien-Yuan Wu; Ying Huang; Barbara A Foster; Yuet Wai Kan; Ah-Ng Kong
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.